Atormac
briv
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 12372  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (1,198 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  Abstract
 » Introduction
 »  Materials and Me...
 » Result
 » Discussion
 » Conclusion
 »  References
 »  Article Figures
 »  Article Tables

 Article Access Statistics
    Viewed3122    
    Printed66    
    Emailed1    
    PDF Downloaded85    
    Comments [Add]    
    Cited by others 2    

Recommend this journal

 


 
Table of Contents    
ORIGINAL ARTICLE
Year : 2014  |  Volume : 62  |  Issue : 2  |  Page : 130-136

A meta-analysis of interleukin-10-1082 promoter genetic polymorphism associated with atherosclerotic risk


Department of Cardiology, Ruijin Hospital Affiliated of Shanghai Jiao Tong University, Shanghai 200025, China

Date of Submission28-Nov-2013
Date of Decision19-Jan-2014
Date of Acceptance06-Apr-2014
Date of Web Publication14-May-2014

Correspondence Address:
Li Chao
Department of Cardiology, Ruijin Hospital Affiliated of Shanghai Jiao Tong University, Ruijing 2nd Road, Shanghai 200025
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.132323

Rights and Permissions

 » Abstract 

Objective: This meta-analysis was conducted to assess the relationship between interleukin-10-1082 G/A single nucleotide polymorphism with atherosclerosis (AS) risk. Materials and Methods: The databases of PubMed, EMBASE, Chinese National Knowledge Infrastructure and Wan-Fang were searched from January 2000 to January 2014. 16 studies (involving 7779 cases and 7271 controls) were finally included. Each eligible study was scored for quality assessment. We adopted the most probably appropriate genetic model (recessive model) after carefully calculation. Between study heterogeneity was explored by subgroup analysis and publication bias was estimated by Begg's funnel plot and Egger's regression test. Results: Statistically significant association was observed between AA genotype with overall AS risk, being mainly in coronary heart disease and stroke subgroups among Asian population, and peripheral artery disease (PAD) subgroup among Caucasians. Conclusions: Interleukin-10-1082 AA genotype is associated with increased overall AS risk. AA carriers of Asians seem to be more susceptible to coronary artery disease and stroke, and Caucasians are more susceptible to PAD.


Keywords: Atherosclerosis, gene, interleukin-10, meta-analysis, single nucleotide polymorphism


How to cite this article:
Chao L, Lei H, Fei J. A meta-analysis of interleukin-10-1082 promoter genetic polymorphism associated with atherosclerotic risk. Neurol India 2014;62:130-6

How to cite this URL:
Chao L, Lei H, Fei J. A meta-analysis of interleukin-10-1082 promoter genetic polymorphism associated with atherosclerotic risk. Neurol India [serial online] 2014 [cited 2021 May 15];62:130-6. Available from: https://www.neurologyindia.com/text.asp?2014/62/2/130/132323



 » Introduction Top


Nowadays, coronary artery disease (CAD) and stroke remains the leading causes of death in developed countries, which are closely related to AS. Traditional risk factors such as smoking, obesity, dyslipidemia, hypertension, and diabetes mellitus are widely accepted. However, with the development of gene technology, more and more scientists have turned their focus on genetic risk factors and gene-environment interaction. As an important proinflammatory cytokine, interleukin-10 (IL-10) is widely known for its anti-inflammatory and B-cell- stimulating function. [1] It seems to be involved in both AS development and its acute complications, such as rupture and thrombosis. [2] Thus, the IL-10 gene appears to be a good candidate for AS studies.

Currently, many epidemiological studies have focused on the association between IL-10-1082 G/A single nucleotide polymorphism (SNP) and AS risk, but the results are controversial. As far as we know, only one published meta-analysis suggested that IL-10-1082 G/A SNP was associated with CAD in Caucasians, [3] but not with the suitable genetic model. Accordingly, we designed this meta-analysis to assess the relationship between IL-10-1082 G/A SNP with AS risk.


 » Materials and Methods Top


Literature search strategy

The electronic databases of PubMed, EMBASE, Chinese National Knowledge Infrastructure and Wan-Fang were searched from January 2000 to January 2014 with the following terms, "Interleukin-10" and "SNP" and "atherosclerosis." The retrieval process was conducted without limitation on language, and the relevant references were also searched manually.

Study selection and data extraction

We evaluated the titles and abstracts of all relevant publications, but excluded case reports, animal experiments, editorials, or review articles. To be included in this meta-analysis, studies must meet the following criteria:

1. Any case-control studies evaluate the association of IL-10-1082 G/A SNP and AS risk;

2. The study reported the characteristics of the study population;

3. Sufficient data could be derived from this study for our meta-analysis;

4. The method of data collection and analysis were statistically acceptable.

Data were extracted by two reviewers (Huang and Jin) independently. Any discrepancy was discussed and resolved by consensus or a third reviewer (Li). The following information were extracted including the first author, publication year, ethnicity, number of cases and controls, type of disease, genotyping method, and genotype frequency. P values for Hardy-Weiberg equilibrium were recalculated in controls.

Quality assessment

The quality of included studies were assessed by two reviewers (Huang and Jin) independently following the criteria of Newcastle-Ottawa Scale (NOS). [4] The third reviewer (Li) checked the results, and a consensus was reached. The criteria of NOS for case-control study involved population selection, comparability, outcome, and ascertainment of exposure in cases and controls. Scores ranged 0-9. Studies with a score less than 6 were excluded.

Statistical analysis

This meta-analysis was performed using Stata 12.0 (StataCorp LP, College Station, TX). The strength of association between IL-10-1082 G/A SNP and AS was assessed by odds ratio (OR) and 95% confidence interval (CI). The Q statistic and I2 statistic [5],[6] were used to test between-study heterogeneity. The Mantel-Haenszel method for fixed effects was adopted if P > 0.1 and I2 <50%, [7] and the Der-Simonian-Laird method for random-effects was used if P < 0.1 and I2 >50%. [5]

Subgroup analysis was used to explore potential heterogeneity. We also performed a sensitivity analysis to test the stability of the results. The dynamic changing of the correlation between IL-10-1082 SNP and AS risk was estimated by cumulative meta-analysis. Finally, publication bias was estimated by Begg's funnel plot and Egger's regression test.

Genetic model determination

To determine the overall gene effect, the model that includes gene was compared with the model without gene in allelic model (A vs. G). If the overall gene effect was statistically significant, further comparisons of OR1 (AA vs. GG), OR2 (GA vs. GG), and OR3 (AA vs. GA) were explored. [8]

If OR1 and OR3 are significant and OR2 is nonsignificant, a recessive model (AA vs. GA + GG) is suggested. If OR1 and OR2 are significant and OR3 is nonsignificant, then a dominant model (AA + GA vs. GG) is implied. If OR2 and OR3 are significant and OR1 is nonsignificant, then a complete overdominant model (GA vs. AA + GG) is suggested. If OR, OR2 and OR3 are all significant, and the effect size of OR1 are twice than that of OR1 and OR2, then a codominant model (AA vs. GA vs. GG) is indicated. Multiple comparisons of genotype effects and possible inheritance model were listed in [Table 1].
Table 1: Multiple comparisons of genotype effects and possible inheritance model

Click here to view



 » Result Top


Literature search and study selection

The flow diagram of the study selection was shown in [Figure 1], and characteristics of included studies were listed in [Table 2]. After the initial search, a total of 251 articles in English and 5 in Chinese were identified. 235 articles were excluded after screening the titles and abstracts, 5 articles were excluded for low quality. Finally, 16 studies [9],[10],[11],[12],[13],[14],[15],[16],[17],[18],[19],[20],[21],[22],[23] catered to the inclusion criteria were included, involving a total of 7779 cases and 7271 controls. The involving AS diseases in this meta-analysis were CAD (including myocardial infarction, ischemic heart disease and acute coronary syndrome), stroke (including ischemic stroke and cerebral infarction) and peripheral artery disease (PAD) (including renal artery stenosis and abdominal aortic aneurysm). Among them nine studies were conducted in Caucasians, six studies were conducted in Asians, and one study was conducted in Latinos.
Figure 1: The flow chart of literature search and study selection

Click here to view
Table 2: Study characteristics of included studies

Click here to view


Determination of genetic model

After preliminary calculation, 'A' allele was found to be the risk factor in allelic model (A vs. G), the pooled OR (95% CI, P value) was 1.22 (1.08, 1.38, P = 0.002) in the random-effect model. The pooled ORs of multiple comparisons OR1, OR2, OR3 were 1.39 (1.09, 1.78, P = 0.009); 1.12 (0.94, 1.34, P = 0.199), and 1.24 (1.05, 1.47, P = 0.012) respectively. The Wald test indicated that OR1 and OR3 were significant (P < 0.05), and OR2 was nonsignificant (P = 0.199), so the genetic model was most likely to be recessive.

In order to find more evidence, OR1, OR2, OR3 were calculated in high quality studies (scores higher than 7). The pooler ORs were 1.39 (1.08, 1.79, P = 0.011); 1.12 (0.94, 1.34, P = 0.214); and 1.23 (1.02, 1.49, P = 0.030), respectively. Hence, the recessive model was determined, and genotype AA was compared with the combined genotype GA-plus-GG.

Overall and subgroup analysis

As shown in [Figure 2], in subgroup analysis based on ethnicity, statistically significant association was observed in Asians and the overall ethnicity, the pooled ORs (95% CI, P value) were 1.43 (1.19, 1.72, P = 0.000) and 1.28 (1.08, 1.52, P = 0.004), respectively.
Figure 2: Forest plot for subgroup analysis based on different ethnicity in recessive model (AA vs. GA-plus-GG)

Click here to view


Further subgroup analysis based on different AS diseases were performed in each ethnicity (CAD in Asians; stroke in Asians; CAD in Caucasians; stroke in Caucasians; PAD in Caucasians and CAD in Latinos). Statistically significant association was observed in stroke subgroup in Asians, and PAD subgroup in Caucasians [Figure 3]. The pooler ORs (95% CI, P value) were 1.55 (1.13, 2.12; P = 0.007) and 1.67 (1.04, 2.69; P = 0.034), respectively. However, we noticed the heterogeneity in CAD subgroup of Asians was acceptable (P = 0.276, I2 = 22.2%), so this subgroup was recalculated in fixed effect model, the pooled OR (95% CI, P value) was 1.37 (1.17, 1.70; P = 0.004).
Figure 3: Forest plot for subgroup analysis based on AS disease in each ethnicity in recessive model (AA vs. GA-plus-GG)

Click here to view


When data sets were sorted according to genotyping method [Figure 4], heterogeneity in each subgroup was successfully removed (P > 0.1 and I2 < 50%), except those only contained one study. Statistically significant association could be observed in amplification refractory mutation system (ARMS) polymerase chain reaction (PCR) and PCR-sequence specific primer (SSP) subgroups. The pooled ORs (95% CI, P value) were 1.55 (1.28, 1.87; P = 0.000) and 2.49 (1.79, 3.46; P = 0.000), respectively.
Figure 4: Forest plot for subgroup analysis based on genotyping method in recessive model (AA vs. GA-plus-GG)

Click here to view


Sensitivity analysis

Sensitivity analysis was conducted by omitting each study in turn [Figure 5]. The results indicated that random-effects estimates before and after the removal of each study were similar at large. The most influencing study was the one conducted by Lio. The pooled OR (95% CI) was 1.28 (1.08, 1.52) before the removal of this study and 1.18 (1.04, 1.35) after the removal of this study, suggesting high stability of this meta-analysis.
Figure 5: Sensitivity analysis performed when each particular study was omitted in turn (random-effect estimates)

Click here to view


Cumulative meta-analysis

Cumulative meta-analysis was conducted by an assortment of the total number of sample size. As shown in [Figure 6], the inclination, though slightly undulated, toward significant association with overall AS risk.
Figure 6: Cumulative meta-analysis of associations between the interleukin-10 -1082 single nucleotide polymorphism and AS risk in recessive model (AA vs. GA+GG)

Click here to view


Publication bias

Potential publication bias was estimated by Begg's funnel plot and Egger's regression test. Dots seemed to be symmetrically distributed through visual assessment [Figure 7], and P values were 0.096 in Begg's test and 0.165 in Egger's test, suggesting no publication bias exist.
Figure 7: Interleukin-10-1082 single nucleotide polymorphism association with AS risk publication bias test

Click here to view



 » Discussion Top


This meta-analysis was performed to make a better understanding of IL-10-1082 G/A SNP with AS risk. We found the risk of AA genotype carriers developing AS was 1.28-fold higher than 'G' allele (GG-plus-GA) carriers in overall ethnicity and 1.43-fold higher in Asian population.

In order to make a more comprehensive understanding, further subgroup analysis was performed based on AS disease in each ethnicity. In Asians, the risk of AA carriers developing CAD and stroke were 1.37-fold higher and 1.55-fold higher than 'G' allele carriers (GA-plus-GG). While in Caucasians, the risk of developing PAD was 1.67-fold higher. This difference could be explained by gene-to-gene or/and gene-to-environmental interactions. Of course, potential publication bias or deficiencies of experiments could also lead to possible false positives.

In this meta-analysis, heterogeneity was effectively removed in subgroup analysis based on genotyping method. Statistically significant association was observed in ARMS PCR and PCR-SSP groups, both indicated higher AS risk of AA genotype. Although heterogeneity shouldn't be the reason that certain PCR method can't be used, but the sensitivity and specificity of PCR technic should be further explored to reduce possible genotyping error.

Human IL-10 gene has been mapped to chromosome 1q31-32 [24] with three important gene locus mutation in the upstream of the transcription start site (-1082G/A, -819C/T and -592C/A). [25] To our knowledge, IL-10 production is partly regulated by genes, but no matter in cytology experiments or epidemiological researches the results are controversial. In vitro experiment conducted by Turner, [25] the presence of GG genotype could down-regulate IL-10 expression. However, Eskdale's et al. study [26] suggested reduced IL-10 production of 'G' allele. As for epidemiology studies, Lio et al. [14] suggested that AA genotype was associated with lower IL-10 production and lower coronary AS risk, but Koch's et al. study [13] indicated that either 'G' or 'A' allele was not associated with coronary AS. So it's necessary to perform this meta-analysis and shed more light on IL-10-1082G/A SNP with AS.

The strength of our meta-analysis could be summarized as follow. Firstly, we cautiously determined the probably most suitable genetic model through carefully calculation. Secondly, potential heterogeneity was successfully removed by subgroup analysis based on genotyping method. Thirdly, sufficient statistical methods were used to get credible conclusions.

There were also some limitations need to be taken into consideration before accepting the results. First, significant heterogeneity was noticed in overall and subgroup analysis, so this part was pooled in the random-effect model, which may lead to inaccurate results. Second, because there is relatively lack of studies on -1082 G/A polymorphism and PAD in Asians, as well as in Latinos, so the results should be interpreted with caution. Third, the human IL-10 production is regulated by complicated gene-environment interaction, the effect of single genetic mutation is limited. So the evidence offered by this meta-analysis should be accepted with caution.


 » Conclusion Top


This meta-analysis provides evidence for IL-10-1082 G/A genetic polymorphism. AA genotype is associated with higher AS risk, but this genetic mutation may play a different role in different genetic and environmental background. We think the results are reliable. However, due to the limitations of this meta-analysis, more large sample and multicenter studies are required.

 
 » References Top

1.de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915-24.  Back to cited text no. 1
    
2.Uyemura K, Demer LL, Castle SC, Jullien D, Berliner JA, Gately MK, et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 1996;97:2130-8.  Back to cited text no. 2
    
3.Wang Y, Zheng J, Liu P, Yu X, Zhou D, Jiang L, et al. Association between the Interleukin 10-1082G>A polymorphism and coronary heart disease risk in a Caucasian population: A meta-analysis. Int J Immunogenet 2012;39:144-50.  Back to cited text no. 3
    
4.Wells G, Shea B, O′connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. [Last accessed on 2011 Oct 20].  Back to cited text no. 4
    
5.Berkey CS, Hoaglin DC, Mosteller F, Colditz GA. A random-effects regression model for meta-analysis. Stat Med 1995;14:395-411.  Back to cited text no. 5
    
6.Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.  Back to cited text no. 6
    
7.Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.  Back to cited text no. 7
[PUBMED]    
8.Thakkinstian A, McElduff P, D′Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med 2005;24:1291-306.  Back to cited text no. 8
    
9.Bown MJ, Burton PR, Horsburgh T, Nicholson ML, Bell PR, Sayers RD. The role of cytokine gene polymorphisms in the pathogenesis of abdominal aortic aneurysms: A case-control study. J Vasc Surg 2003;37:999-1005.  Back to cited text no. 9
    
10.Donger C, Georges JL, Nicaud V, Morrison C, Evans A, Kee F, et al. New polymorphisms in the interleukin-10 gene - Relationships to myocardial infarction. Eur J Clin Invest 2001;31:9-14.  Back to cited text no. 10
    
11.Fragoso JM, Vallejo M, Alvarez-León E, Delgadillo H, Peña-Duque MA, Cardoso-Saldaña G, et al. Alleles and haplotypes of the interleukin 10 gene polymorphisms are associated with risk of developing acute coronary syndrome in Mexican patients. Cytokine 2011;55:29-33.  Back to cited text no. 11
    
12.George S, Ruan XZ, Navarrete C, Turner D, Reynard M, Sweny P, et al. Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10. Tissue Antigens 2004;63:470-5.  Back to cited text no. 12
    
13.Koch W, Kastrati A, Böttiger C, Mehilli J, von Beckerath N, Schömig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001;159:137-44.  Back to cited text no. 13
    
14.Lio D, Candore G, Crivello A, Scola L, Colonna-Romano G, Cavallone L, et al. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: Genetic background of male centenarians is protective against coronary heart disease. J Med Genet 2004;41:790-4.  Back to cited text no. 14
[PUBMED]    
15.Lorenzová A, Stanek V, Gebauerová M, Bohuslavová R, Stávek P, Hubácek JA, et al. High-sensitivity C-reactive protein concentration in patients with myocardial infarction-environmental factors, and polymorphisms in interleukin-10 and CD14 genes. Clin Chem Lab Med 2007;45:855-61.  Back to cited text no. 15
    
16.Marousi S, Ellul J, Antonacopoulou A, Gogos C, Papathanasopoulos P, Karakantza M. Functional polymorphisms of interleukin 4 and interleukin 10 may predict evolution and functional outcome of an ischaemic stroke. Eur J Neurol 2011;18:637-43.  Back to cited text no. 16
    
17.Munshi A, Rajeshwar K, Kaul S, Al-Hazzani A, Alshatwi AA, Sai Babu M, et al. Interleukin-10-1082 promoter polymorphism and ischemic stroke risk in a South Indian population. Cytokine 2010;52:221-4.  Back to cited text no. 17
    
18.Babu BM, Reddy BP, Priya VH, Munshi A, Rani HS, Latha GS, et al. Cytokine gene polymorphisms in the susceptibility to acute coronary syndrome. Genet Test Mol Biomarkers 2012;16:359-65.  Back to cited text no. 18
    
19.Tuttolomondo A, Di Raimondo D, Forte GI, Casuccio A, Vaccarino L, Scola L, et al. Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine 2012;58:398-405.  Back to cited text no. 19
    
20.Yu GI, Cho HC, Cho YK, Park HS, Yoon HJ, Kim HS, et al. Association of promoter region single nucleotide polymorphisms at positions -819C/T and -592C/A of interleukin 10 gene with ischemic heart disease. Inflamm Res 2012;61:899-905.  Back to cited text no. 20
    
21.Jin L, Ni P, Wu J, Fu Y, Ge H. The correlation between gene polymorphism of IL-10-819 C/T and-1082 G/A and cerebral infarction. Lab Med 2011;26:717-21.  Back to cited text no. 21
    
22.Lin K. Study on the relationship between interleukin-10 gene polymorphisms and cerebral infarction, Fujian Medical University, 2009. Available from: http://www.d.wanfangdata.com.cn/Thesis_Y1487152.aspx.  Back to cited text no. 22
    
23.Wang J, Chen Z, Ma G. Relationship bewteen interleukin-10 gene -1082G/A, -819C/T polymorphism and premuture coronary heart disease. J Clin Cardiol 2007;23:3-6.  Back to cited text no. 23
    
24.Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 1992;148:3618-23.  Back to cited text no. 24
    
25.Turner DM1, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8.  Back to cited text no. 25
    
26.Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 1998;95:9465-70.  Back to cited text no. 26
    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7]
 
 
    Tables

  [Table 1], [Table 2]

This article has been cited by
1 Association Between 3 IL-10 Gene Polymorphisms and Cardiovascular Disease Risk
Yang Xuan,Lina Wang,Hong Zhi,Xiaoshan Li,Pingmin Wei
Medicine. 2016; 95(6): e2846
[Pubmed] | [DOI]
2 Association ofinterleukin-10promoter region polymorphisms with risk factors of Atherosclerosis
G. I. Yu,S.-E. Jun,H.-C. Cho,K. O. Park,J.-H. Chung,D. H. Shin,I. S. Chung
International Journal of Immunogenetics. 2015; 42(1): 31
[Pubmed] | [DOI]



 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow